You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR MARGENZA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MARGENZA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04425018 ↗	MARGetuximab Or Trastuzumab (MARGOT)	Recruiting	MacroGenics	Phase 2	2020-07-13	The purpose of this study is to determine how well participants with stage II-III HER2-positive breast cancer respond to pre-operative treatment using one of two different combinations of drugs. Drugs and Combinations used: - Paclitaxel, Pertzumab and Margetuximab (Margenza) - Paclitaxel, Pertzumab and Trastuzumab (Herceptin)
NCT04425018 ↗	MARGetuximab Or Trastuzumab (MARGOT)	Recruiting	Translational Breast Cancer Research Consortium	Phase 2	2020-07-13	The purpose of this study is to determine how well participants with stage II-III HER2-positive breast cancer respond to pre-operative treatment using one of two different combinations of drugs. Drugs and Combinations used: - Paclitaxel, Pertzumab and Margetuximab (Margenza) - Paclitaxel, Pertzumab and Trastuzumab (Herceptin)
NCT04425018 ↗	MARGetuximab Or Trastuzumab (MARGOT)	Recruiting	Dana-Farber Cancer Institute	Phase 2	2020-07-13	The purpose of this study is to determine how well participants with stage II-III HER2-positive breast cancer respond to pre-operative treatment using one of two different combinations of drugs. Drugs and Combinations used: - Paclitaxel, Pertzumab and Margetuximab (Margenza) - Paclitaxel, Pertzumab and Trastuzumab (Herceptin)
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MARGENZA

Condition Name

Chart
Table

Condition Name for MARGENZA
Intervention	Trials
Breast Cancer	1
HER2-positive Breast Cancer	1
Stage II Breast Cancer	1
Stage III Breast Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MARGENZA
Intervention	Trials
Breast Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MARGENZA

Trials by Country

Map
Table

Trials by Country for MARGENZA
Location	Trials
United States	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MARGENZA
Location	Trials
Washington	1
Texas	1
Pennsylvania	1
North Carolina	1
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MARGENZA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MARGENZA
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MARGENZA
Clinical Trial Phase	Trials
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MARGENZA

Sponsor Name

Chart
Table

Sponsor Name for MARGENZA
Sponsor	Trials
MacroGenics	1
Translational Breast Cancer Research Consortium	1
Dana-Farber Cancer Institute	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MARGENZA
Sponsor	Trials
Other	2
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.